Cyclacel Pharma (CYCC) Reports Q3 Loss of $0.11/Share
Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.11), versus ($0.18) reported last year.
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.11), versus ($0.18) reported last year.
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.